USD 1.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | -33.57 USD | 99.93% |
2023 | -49.06 Thousand USD | 94.0% |
2022 | -742.4 Thousand USD | 62.83% |
2021 | -2.28 Million USD | -517.17% |
2020 | -356.55 Thousand USD | -16255.69% |
2019 | -2175.00 USD | 0.0% |
2018 | -2180.00 USD | 0.0% |
2014 | -615.53 Thousand USD | 1581.56% |
2013 | -7629.00 USD | -339721.83% |
2012 | -2.25 USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -2210.00 USD | 67.31% |
2024 Q3 | -6500.00 USD | -194.25% |
2024 Q4 | -74.23 Thousand USD | -62.69% |
2024 Q1 | -6760.00 USD | -146.24% |
2024 FY | - USD | -82.96% |
2023 Q1 | -49.67 Thousand USD | 78.39% |
2023 Q2 | 1450.00 USD | 102.92% |
2023 Q4 | 14.62 Thousand USD | 324.58% |
2023 FY | - USD | 94.0% |
2023 Q3 | -6510.00 USD | -548.97% |
2022 Q4 | -229.86 Thousand USD | -536.0% |
2022 FY | - USD | 62.83% |
2022 Q3 | 52.72 Thousand USD | 129.85% |
2022 Q2 | -176.63 Thousand USD | 61.94% |
2022 Q1 | -464.14 Thousand USD | 32.25% |
2021 FY | - USD | -517.17% |
2021 Q4 | -685.12 Thousand USD | -21.34% |
2021 Q3 | -564.62 Thousand USD | 10.26% |
2021 Q1 | -321.63 Thousand USD | -140.83% |
2021 Q2 | -629.17 Thousand USD | -95.62% |
2020 Q2 | -11.7 Thousand USD | 35.61% |
2020 FY | - USD | -16255.69% |
2020 Q4 | -133.55 Thousand USD | 31.43% |
2020 Q3 | -194.76 Thousand USD | -1563.82% |
2020 Q1 | -18.18 Thousand USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2015 Q2 | -887.85 Thousand USD | 22.33% |
2015 Q1 | -1.14 Million USD | -1025.9% |
2015 Q3 | -885.59 Thousand USD | 0.25% |
2014 Q4 | 123.45 Thousand USD | 5134.83% |
2014 FY | - USD | 1581.56% |
2014 Q3 | -2452.00 USD | 20.7% |
2014 Q2 | -3092.00 USD | 36.67% |
2014 Q1 | -4882.00 USD | -121.11% |
2013 Q4 | -2208.00 USD | 0.32% |
2013 Q3 | -2215.00 USD | 28.78% |
2013 Q2 | -3110.00 USD | -3106.19% |
2013 FY | - USD | -339721.83% |
2013 Q1 | -97.00 USD | -26844.44% |
2012 Q4 | -0.36 USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
GSRX Industries Inc. | - USD | Infinity% |
High Sierra Technologies, Inc. | -181.97 Thousand USD | 99.982% |
Instadose Pharma Corp. | - USD | Infinity% |